Cervomed to participate in the 4th annual roth healthcare opportunities conference

Boston, oct. 02, 2025 (globe newswire) -- cervomed inc. (nasdaq: crvo), a clinical stage company focused on developing treatments for age-related neurologic disorders (cervomed or the company), today announced that company management will participate in a panel discussion and one-on-one meetings at the upcoming 4th annual roth healthcare opportunities conference being held in new york, ny, on thursday, october 9, 2025.
CRVO Ratings Summary
CRVO Quant Ranking